Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicity

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3356-3365

  Angelov, Georgi S ^a   Guillaume, Philippe ^a   Cebecauer, Marek ^a   Bosshard, Giovanna ^a   Dojcinovic, Danijel ^a   Baumgaertner, Petra ^b   Luescher, Immanuel F ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GLYCOPROTEIN; GLYCOPROTEIN GP 33; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; POLYPROPYLENE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL DEATH; CELL KILLING; CELL MEDIATED CYTOTOXICITY; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SOLUBILITY; VIRUS MENINGITIS;

EID: 33644838915     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3356     Document Type: Article

References (53)

1. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
2. Ogg, G. S., and A. J. McMichael. 1998. HLA-peptide tetrameric complexes. Curr. Opin. Immunol 10: 393-396.
3. Schneck, J. P. 2000. Monitoring antigen-specific T cells using MHC-Ig dimers. Immunol. Invest. 29: 163-169.
4. Doucey, M. A., D. F. Legler, N. Boucheron, J. C. Cerottini, C. Bron, and I. F. Luescher. 2001. CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts. Eur. J. Immunol. 31: 1561-1570.
5. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CDS in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med 191: 335-346.
6. Anikeeva, N., K. Somersalo, T. N. Sims, V. K. Thomas, M. L. Dustin, and Y. Sykulev. 2005. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 102: 6437-6442.
7. 3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol Chem. 278: 26983-26991.
8. Stinchcombe, J. C., G. Bossi, S. Booth, and G. M. Griffiths. 2001. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15: 751-761.
9. Makgoba, M. W., M. E. Sanders, G. E. Ginther Luce, E. A. Gugel, M. L. Dustin, T. A. Springer, and S. Shaw. 1988. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur. J. Immunol. 18: 637-640.
10. Ybarrondo, B., A. M. O'Rourke, A. A. Brian, and M. F. Mescher. 1994. Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation. J. Exp. Med. 179: 359-363.
11. + T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 98: 12624-12629.
12. Ybarrondo, B., A. M. O'Rourke, J. B. McCarthy, and M. F. Mescher. 1997. Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling. Immunology 91: 186-192.
13. Schneck, J., W. L. Maloy, J. E. Coligan, and D. H. Margulies. 1989. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 56: 47-55.
14. O'Herrin, S. M., J. E. Slansky, Q. Tang, M. A. Markiewicz, T. F. Gajewski, D. M. Pardoll, J. P. Schneck, and J. A. Bluestone. 2001. Antigen-specific blockade of T cells in vivo using dimeric MHC peptide. J. Immunol. 167: 2555-2560.
15. Dal Porto, J., T. E. Johansen, B. Catipovic, D. J. Parfiit, D. Tuveson, U. Gether, S. Kozlowski, D. T. Fearon, and J. P. Schneck. 1993. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl. Acad Sci. USA 90: 6671-6675.
16. + T cells by a soluble dimeric peptide-MHC class II chimera. Nat. Immunol. 3: 383-391.
17. Burrows, G. G., K. L. Adlard, B. F. Bebo, Jr., J. W. Chang, K. Tenditnyy, A. A. Vandenbark, and H. Offner. 2000. Regulation of encephalitogenic T cells with recombinant TCR ligands. J. Immunol. 164: 6366-6371.
18. Appel, H., N. P. Seth, L. Gauthier, and K. W. Wucherpfennig. 2001. Anergy induction by dimeric TCR ligands. J. Immunol. 166: 5279-5285.
19. Masteller, E. L., M. R. Warner, W. Ferlin, V. Judkowski, D. Wilson, N. Glaichenhaus, and J. A. Bluestone. 2003. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 171: 5587-5595.
20. + CTL. J. Immunol. 174: 6809-6819.
21. + cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers. J. Biol. Chem. 280: 23820-23828.
22. Guillaume, P., D. F. Legler, N. Boucheron, M. A. Doucey, J. C. Cerottini, and I. F. Luescher. 2003. Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis. J. Biol. Chem. 278: 4500-4509.
23. + T cells through transfer of the peptide to T cell MHC molecules. Proc. Natl. Acad. Sci. USA 99: 13729-13734.
24. b molecules. Proc. Natl. Acad. Sci. USA 99: 13735-13740.
25. + cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 87: 9015-9019.
26. Luescher, I. F., P. Romero, J. C. Cerottini, and J. L. Maryanski. 1991. Specific binding of antigenic peptides to cell-associated MHC class I molecules. Nature 351: 72-74.
27. Kozono, H., J. White, J. Clements, P. Marrack, and J. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369: 151-154.
28. Weiss, G. A., R. J. Valentekovich, E. J. Collins, D. N. Garboczi, W. S. Lane, S. L. Schreiber, and D. C. Wiley. 1996. Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine. Proc. Natl. Acad. Sci. USA 93: 10945-10948.
29. Luescher, I. F., P. Romero, D. Kuznetsov, D. Rimoldi, P. Coulie, J. C. Cerottini, and C. V. Jongeneel. 1996. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44. J. Biol. Chem. 271: 12463-12471.
30. Velloso, L. M., J. Michaelsson, H. G. Ljunggren, G. Schneider, and A. Achour. 2004. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition. J. Immunol. 172: 5504-5511.
31. d-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. J. Exp. Med. 185: 629-640.
32. d-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity 3: 51-63.
33. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. Oldstone. 1990. Vaccination and protection from a lethal vital infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178: 393-400.
34. b molecules. Virology 234: 62-73.
35. Lopez, J. A., I. F. Luescher, and J. C. Cerottini. 1992. Direct binding of peptides to MHC class I molecules on living cells: analysis at the single cell level. J. Immunol. 149: 3827-3835.
36. Angelov, G. S., M. Tomkowiak, A. Marcais, Y. Leverrier, and J. Marvel. 2005. FH3 ligand-generated murine plasmacytoid and conventional dendritic cells differ in their capacity to prime naive CD8 T cells and to generate memory cells in vivo. J. Immunol. 175: 189-195.
37. Meyer, D. M., M. L. Dustin, and C. P. Carron. 1995. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J. Immunol. 155: 3578-3584.
38. Lyons, D. S., S. A. Lieberman, J. Hampl, J. J. Boniface, Y. Chien, L. J. Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5: 53-61.
39. Rosette, C., G. Werlen, M. A. Daniels, P. O. Holman, S. M. Alam, P. J. Travers, N. R. J. Gascoigne, E. Palmer, and S. C. Jameson. 2001. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15: 59-70.
40. + CTL clones is determined by the frequency of serial TCR engagement. J. Immunol. 161: 553-562.
41. Arora, P. S., A. Z. Ansari, T. P. Best, M. Ptashne, and P. B. Dervan. 2002. Design of artificial transcriptlonal activators with rigid poly-L-proline linkers. J. Am. Chem. Soc. 124: 13067-13071.
42. Cochran, J. R., T. O. Cameron, J. D. Stone, J. B. Lubetsky, and L. J. Stern. 2001. Receptor proximity, not intermolecular orientation, is critical for triggering T-cell activation. J. Biol. Chem. 276: 28068-28074.
43. Yamaguchi, H., and W. A. Hendrickson. 1996. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384: 484-489.
44. 2. J. Cell Biol. 167: 1241-1253.
45. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
46. Frank, S. J. 2002. Receptor dimerization in GH and erythropoietin action: it takes two to tango, but how? Endocrinology 143: 2-10.
47. Livnah, O., E. A. Stura, S. A. Middleton, D. L. Johnson, L. K. Jolliffe, and I. A. Wilson. 1999. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283: 987-990.
48. Schamel, W. W. A., I. Arechaga, R. M. Risueno, H. M. van Santen, P. Cabezas, C. Risco, J. M. Valpuesta, and B. Alarcon. 2005. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J. Exp. Med. 202: 493-503.
49. Fernandez-Miguel, G., B. Alarcon, A. Iglesias, H. Bluethmann, M. Alvarez-Mon, E. Sanz, and A. de la Hera. 1999. Multivalent structure of an αβT cell receptor. Proc. Natl. Acad. Sci. USA 96: 1547-1552.
50. Marano, N., M. Crawford, and B. Govindan. 1997. Characterization of the detergent insolubility of the T cell receptor for antigen. Mol. Immunol. 34: 967-976.
51. Magee, T., N. Pirinen, J. Adler, S. N. Pagakis, and I. Parmryd. 2002. Lipid rafts: cell surface platforms for T cell signaling. Biol. Res. 35: 127-131.
52. Casares, S., C. S. Zong, D. L. Radu, A. Miller, C. A. Bona, and T. D. Brumeanu. 1999. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation. J. Exp. Med. 190: 543-553.
53. + T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J. Immunol. 163: 4826-4832.